Shailender Bhatia, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Nektar Therapeutics
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    02/28/2023
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Trisalus Life Sciences
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Xencor
    Topic:
    Research funding
    Date added:
    03/09/2023
    Date updated:
    02/13/2024
    Relationship end date:
    03/10/2025
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    BMS
    Topic:
    Advisory board
    Date added:
    02/13/2024
    Date updated:
    02/13/2024
    Relationship end date:
    07/20/2023
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    Incyte
    Topic:
    Consultant
    Date added:
    02/13/2024
    Date updated:
    02/13/2024
    Relationship end date:
    03/15/2023

Pages

Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies